Clinical Trial Update: Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 dose titration study completed to evaluate safety and effects of CK-2017357 in patients with amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• CK-2017357

Snippet

Sponsor: Cytokinetics | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED